Trial intelligence / Profile preview

Vitamin D with Omega-3 or Metformin in Knee Osteoarthritis

NCT06328426Not yet recruiting

Sponsor
Assiut University
Start
Aug 2024
Primary completion
Aug 2026
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of liquid metformin (Aspargo Labs) in osteoarthritis (OA) (3 arms), sponsored by Assiut University. Primary endpoint: Effusion-synovitis volume on musculoskeletal ultrasound at 4 months. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06328426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06328426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call